| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |